James Burke
Neurology · Willow Grove, PANPI 1679670129
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by Akcea Therapeutics, Inc. at 24.1% of the total. Reporting peaked in 2019 at $1,886 and has fallen 98.8% since, to $23 in 2025.
Across 121 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Akcea Therapeutics, Inc.$628
- Novartis$359
- Sanofi$187
- CSL Behring$164
- EMD Serono, Inc.$137
- Avanir Pharmaceuticals, Inc.$106
- plus $1K from 25 others
What the payments were for
- Speaking & faculty fees$642%
- Food & beverage$2,52397%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Akcea Therapeutics, Inc. | 11 | $628 |
| Novartis | 18 | $359 |
| Sanofi | 10 | $187 |
| CSL Behring | 8 | $164 |
| EMD Serono, Inc. | 11 | $137 |
| Avanir Pharmaceuticals, Inc. | 6 | $106 |
| Biogen | 6 | $106 |
| AbbVie(2 entities) | 6 | $93 |
| UCB, Inc. | 5 | $89 |
| Amgen | 4 | $84 |
| Adamas Pharmaceuticals, Inc. | 4 | $78 |
| Mallinckrodt Enterprises LLC | 3 | $72 |
| Acorda Therapeutics, Inc | 3 | $64 |
| MDD US Operations, LLC | 3 | $50 |
| Vertical Pharmaceuticals, LLC | 3 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Kyowa Kirin, Inc. | 2 | $32 |
| Tanabe Pharma America, Inc. | 2 | $29 |
| Tersera Therapeutics LLC | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Neurelis, Inc. | 1 | $11 |
| Harmony Biosciences LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,602 in reported general payments places this provider in the 65th percentile of 941 neurology providers in Pennsylvania.
Other neurology in Willow Grove
- Lee HarrisWillow Grove$152K
- Daniel KremensPhiladelphia$1.8M
- Thomas LeistPhiladelphia$1.4M
- Jill Giordano FarmerPhiladelphia$1.2M
- Ravi DukkipatiYork$936K
- Brad KleinAbington$927K
- Stephanie Nahas-GeigerPhiladelphia$786K
- John KhouryAbington$686K
- Amit Bar-OrPhiladelphia$596K
- Behrang SaminejadAllentown$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.